Cerity Partners’s Acadia Healthcare ACHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $224K | Buy |
+9,578
| New | +$173K | ﹤0.01% | 2810 |
|
|
2025
Q4 | – | Sell |
-10,887
| Closed | -$270K | – | 2873 |
|
|
2025
Q3 | $270K | Sell |
10,887
-55,869
| -84% | -$1.25M | ﹤0.01% | 2348 |
|
|
2025
Q2 | $1.51M | Buy |
66,756
+29,872
| +81% | +$708K | ﹤0.01% | 1341 |
|
|
2025
Q1 | $1.12M | Sell |
36,884
-13,176
| -26% | -$502K | ﹤0.01% | 1378 |
|
|
2024
Q4 | $2.67M | Buy |
50,060
+17,138
| +52% | +$773K | 0.01% | 979 |
|
|
2024
Q3 | $2.09M | Buy |
32,922
+10,019
| +44% | +$723K | ﹤0.01% | 1076 |
|
|
2024
Q2 | $1.55M | Sell |
22,903
-2,018
| -8% | -$141K | ﹤0.01% | 1033 |
|
|
2024
Q1 | $1.97M | Buy |
24,921
+21,377
| +603% | +$1.75M | 0.01% | 975 |
|
|
2023
Q4 | $276K | Buy |
+3,544
| New | +$262K | ﹤0.01% | 1564 |
|
|
2023
Q3 | – | Sell |
-40,852
| Closed | -$3.25M | – | 1393 |
|
|
2023
Q2 | $3.25M | Buy |
40,852
+1,355
| +3% | +$97.9K | 0.01% | 603 |
|
|
2023
Q1 | $2.85M | Sell |
39,497
-30
| -0.1% | -$2.34K | 0.01% | 610 |
|
|
2022
Q4 | $3.25M | Buy |
39,527
+778
| +2% | +$64.1K | 0.02% | 441 |
|
|
2022
Q3 | $3.03M | Buy |
38,749
+136
| +0.4% | +$10.9K | 0.04% | 311 |
|
|
2022
Q2 | $2.61M | Sell |
38,613
-2,959
| -7% | -$206K | 0.03% | 356 |
|
|
2022
Q1 | $2.73M | Sell |
41,572
-427
| -1% | -$24.8K | 0.04% | 274 |
|
|
2021
Q4 | $2.55M | Buy |
41,999
+996
| +2% | +$59.4K | 0.04% | 282 |
|
|
2021
Q3 | $2.62M | Buy |
41,003
+12
| +0% | +$758 | 0.06% | 227 |
|
|
2021
Q2 | $2.57M | Sell |
40,991
-2,003
| -5% | -$126K | 0.06% | 230 |
|
|
2021
Q1 | $2.46M | Sell |
42,994
-112
| -0.3% | -$6.06K | 0.06% | 226 |
|
|
2020
Q4 | $2.17M | Sell |
43,106
-6,445
| -13% | -$257K | 0.07% | 198 |
|
|
2020
Q3 | $1.46M | Sell |
49,551
-200
| -0.4% | -$5.81K | 0.06% | 204 |
|
|
2020
Q2 | $1.25M | Sell |
49,751
-10,130
| -17% | -$253K | 0.07% | 175 |
|
|
2020
Q1 | $1.1M | Sell |
59,881
-498
| -0.8% | -$14.3K | 0.07% | 191 |
|
|
2019
Q4 | $2.01M | Buy |
60,379
+17,553
| +41% | +$550K | 0.1% | 162 |
|
|
2019
Q3 | $1.33M | Buy |
+42,826
| New | +$1.3M | 0.08% | 212 |
|
|
2019
Q2 | – | Sell |
-21,996
| Closed | -$645K | – | 477 |
|
|
2019
Q1 | $645K | Sell |
21,996
-26,014
| -54% | -$737K | 0.04% | 294 |
|
|
2018
Q4 | $1.23M | Sell |
48,010
-6,105
| -11% | -$211K | 0.08% | 202 |
|
|
2018
Q3 | $1.91M | Buy |
54,115
+5,928
| +12% | +$236K | 0.13% | 171 |
|
|
2018
Q2 | $1.97M | Buy |
48,187
+23,750
| +97% | +$958K | 0.15% | 151 |
|
|
2018
Q1 | $957K | Buy |
24,437
+8,244
| +51% | +$302K | 0.07% | 233 |
|
|
2017
Q4 | $528K | Sell |
16,193
-20,275
| -56% | -$703K | 0.04% | 331 |
|
|
2017
Q3 | $1.74M | Buy |
36,468
+2,917
| +9% | +$142K | 0.12% | 173 |
|
|
2017
Q2 | $1.66M | Buy |
33,551
+6,236
| +23% | +$276K | 0.14% | 133 |
|
|
2017
Q1 | $1.19M | Buy |
+27,315
| New | +$1.11M | 0.1% | 172 |
|
Other funds holding ACHC
KCM
VPM
DM
DCM
ABI
VCM
Cerity Partners's ACHC Position: Q1 2026 in Review
Cerity Partners opened a new position in Acadia Healthcare (ACHC) in Q1 2026: 9,578 shares worth $224K. The stake represents ﹤0.01% of the portfolio and ranks #2810 among its holdings. This is a return to the name: Cerity Partners previously reported a position in ACHC as recently as Q3 2025.
Cerity Partners first reported a position in ACHC in Q1 2017 and has held it in 34 quarters since. The position peaked at $3.25M in Q4 2022. 295 funds tracked by Wall St. Rank hold ACHC as of Q1 2026.
- Cerity Partners held 9,578 shares of Acadia Healthcare worth $224K as of Q1 2026.
- Acadia Healthcare was a new Cerity Partners position in Q1 2026.
- Acadia Healthcare made up ﹤0.01% of Cerity Partners's portfolio in Q1 2026, its #2810 holding.
- Cerity Partners first reported a position in Acadia Healthcare in Q1 2017 and has held it in 34 quarters since.
- Cerity Partners's Acadia Healthcare position peaked at $3.25M in Q4 2022.
- 295 funds tracked by Wall St. Rank held Acadia Healthcare as of Q1 2026.
Based on Cerity Partners's 13F filing for Q1 2026, filed 15 May 2026.